Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

Peter Vickerman, Natasha K. Martin, Anuradha Roy, Tara Beattie, Don Des Jarlais, Steffanie Strathdee, Lucas Wiessing, Matthew Hickman, Y. P. Bao, Waleska Caiaffa, Gonzalo Ralón, Diana Rossi, Laura Camoni, Barbara Suligoi, Nejc Bergant, Peer Brehm Christensen, Óscar Duarte, Sofia Santos, Carla Ribeiro, Ksenia EritsyanVeronika Odinokova, Konstantin Vyshinsky, Cinta Folch, Jordi Casabona, Anastasios Fotiou, Vivian Hope, Ilonka Horvath, Sharon Hutchinson, Violeta Bogdanova, Raina Ilieva, Jean Long, Catharina Matheï, Alexandr Muravsky, Leonie Prasad, Henrique Barros, Magdalena Rosinska, Marie Jauffret Roustide, Otilia Scutelniciuc, Fernando Vallejo, Uusküla Anneli, Bruno Guarita, Andre Noor, Luis de la Fuente, Marc Roelands, Michaël Hogge

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds